Concepedia

Joachim T. Siaw

JT

Statistics

Publications

8

Citations

274

H-Index

8

Active since

2016

Affiliations

University of Gothenburg(Current)

Zhengzhou University

Ghent University

Karolinska Institutet

Zhengzhou Children's Hospital

Joachim T. Siaw is an author at University of Gothenburg specializing in oncogenic signaling pathways, molecular oncology, and oncology.

ORCID

Publications per year

2016–2022

8

Publications

8

ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

Joanna Szydzik, Dan E. Lind, Badrul Arefin et al. · Nature Communications · 2021 · 57 citations · Full text

, , +17

Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells,<i>Drosophila</i>and mice

Joachim T. Siaw, Haiying Wan, Kathrin Pfeifer et al. · Oncotarget · 2016 · 54 citations · Full text

, , +17

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden et al. · Cell Reports · 2020 · 53 citations · Full text

, , +17

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

Jikui Guan, Susanne Fransson, Joachim T. Siaw et al. · Molecular Case Studies · 2018 · 48 citations · Full text

, , +17

Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent

Jikui Guan, Georg Wolfstetter, Joachim T. Siaw et al. · Oncotarget · 2016 · 19 citations · Full text

, , +17

1–5 of 8